maintain ep less margin error
result support narr price pressur stapl
report organ sale ep actual better anticip
off-set gross margin worst margin level seen year
input cost y/i price incl neg price emerg
market con tissu littl quell concern price
deflat across stapl second organ sale better vs model
strong cold/flu season driver con tissu unit acceler
stack profit flow-through weak ct op profit y/i margin
raw materi weigh lastli maintain outlook organ
sale ep despit increment commod inflat
expect mid-point outlook assum modestli higher net sell price
despit recent result show price challeng prior expect price/mix flat
slightli lower discretionari spend includ advertis potenti
flexibl tax line come vs fy guidanc
maintain ep less margin error fewer lever
proven one abl cost manag stapl evidenc
year strong contribut save restructur program
announc last quarter start contribut said margin clearli
pressur market left concern whether earn expect need
reset invest behind growth increment capabl better serv
evolv retail environ maintain ep toward low end
mgmt rang org sale vs prior well slightli better fx
sg fewer lever meet outlook unforeseen challeng aris
view includ lower price realiz expect hsd price bath tissu sale
commod inflat step chang competit
lower price object reiter neutral
new po ep vs vs
average valuat reflect challeng see catalyst
n-t bar construct view group expect
materi ep season
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
manufactur tissu
person care healthcar product global
viva scott depend pois well andrex
uk
lead market share posit
larger household product
categori toilet tissu diaper paper
towel facial tissu save strong
fund reinvest dividend peer-
best amongst mega cap howev
growth slow amidst increas competit
deceler volum catalyst
next year view believ
share fairli valu
pleas see tabl result segment well key comments/callout
higher promot spend babi adult care categori
volum increas eastern europ latin america
declin china
volum declin driven mainli south korea
volum benefit soft perform year-ago
period saw declin addit volum reflect
higher promot spend well sever cold/flu season
drive demand facial tissu mix impact higher
volum increas driven asia pacif
volum increas driven south korea
volum grew major product categori includ msd
growth wiper
volum growth driven asia-pacif
organ sale ep guid maintain
maintain outlook organ sale ep though
compon guidanc chang expect higher benefit fx
price well impact raw materi seen
expect drive organ sale
fx sale
flat slightli
flat
good sold report
good sold
sale
incom equiti interest
share net incom equiti compani
share net incom equiti compani
incom discontinu oper report
incom discontinu oper
restructur
mo end decemb
k-c profession
good sold report
good sold
sale
sale
sale
depreci amort expens
incom equiti interest
share net incom equiti compani report
share net incom equiti compani
incom discontinu oper report
incom discontinu oper
restructur
price object driven target price-to-earnings ep estim
discount large-cap hpc reflect risk around broad slowdown categori
growth driven increas competit activ also sluggish birth rate
potenti privat label increas penetr core categori also risk
could slow volum growth pressur margin
downsid risk price object tighter price environ worsen
slowdown develop market macro set greater expect need
reinvest higher level competit
upsid risk faster growth emerg market less competit pressur key
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
